Status:
NOT_YET_RECRUITING
Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH
Lead Sponsor:
Assiut University
Conditions:
BPH (Benign Prostatic Hyperplasia)
Eligibility:
MALE
50-80 years
Phase:
NA
Brief Summary
The study aims to evaluate the role of TRUS in improving the efficacy and safety of endoscopic enucleation of prostate and TURP.
Detailed Description
Standard TURP is an established procedure for managing BPH but has limitations, including the risk of incomplete adenoma removal and complications such as bleeding. Research on transurethral enucleati...
Eligibility Criteria
Inclusion
- Male patients aged 50-80 years
- Diagnosed with benign prostatic hyperplasia (BPH) and scheduled for TURP or prostatic adenoma enucleation.
- The patients have clear indication for endoscopic surgery (according to the guidelines).
- Clinically fit patients for surgery.
- Signed an informed consent.
Exclusion
- • Prostate cancer
- Previous urethral or prostate surgery
- Neurogenic bladder
- Urethral stricture
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT06922968
Start Date
April 1 2025
End Date
October 1 2026
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt